T2 Biosystems IncのEV/Sales
T2 Biosystems IncのEV/Salesは何ですか。
T2 Biosystems IncのEV/Salesは10.64です。
EV/Salesの定義は何ですか。
Enterprise value to sales ratio compares a company’s total value to its sales.
ttm (trailing twelve months)
Enterprise value/sales is a valuation ratio that compares the company's enterprise value to its annual sales. It indicates the company's capacity to generate free cash flow. In general, the lower the ratio, the cheaper the company is.
EV/Sales is most often calculated as cash and cash equivalents subtracted from the sum of market capitalization and debt and divided by annual sales. Many analysts consider EV/sales to be a more accurate metric than Price/Sales as it considers both debt and equity holders in its calculation. One of the limitations of the calculation is that sales do not take into account a company's taxes or expenses.
NASDAQのセクタHealth CareにおけるEV/Salesの企業と比べるT2 Biosystems Inc
T2 Biosystems Incは何をしますか。
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
T2 Biosystems Incと類似のev/sales
- Poly Ppty Dvlp Co LtdのEV/Salesは10.62です。
- Inventiva SAのEV/Salesは10.62です。
- IM+ CapitalsのEV/Salesは10.63です。
- Telesites SAB de CVのEV/Salesは10.63です。
- RioCan Real Estate Investment TrustのEV/Salesは10.63です。
- Network-1 Technologies IncのEV/Salesは10.64です。
- T2 Biosystems IncのEV/Salesは10.64です。
- Lattice SemiconductorのEV/Salesは10.65です。
- CardaxのEV/Salesは10.66です。
- LXI REIT PlcのEV/Salesは10.66です。
- Evotec SEのEV/Salesは10.67です。
- Eve & CoのEV/Salesは10.67です。
- FSAのEV/Salesは10.68です。